GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf1
|
ENSRNOG00000003443 | Kruppel like factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Klf1 | rn6_v1_chr19_+_26016382_26016382 | 0.35 | 7.3e-11 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr16_+_10417185 | 49.54 |
ENSRNOT00000082186
|
Anxa8
|
annexin A8 |
chr7_+_11077411 | 44.40 |
ENSRNOT00000007117
|
S1pr4
|
sphingosine-1-phosphate receptor 4 |
chr10_-_104628676 | 43.97 |
ENSRNOT00000010466
|
Unc13d
|
unc-13 homolog D |
chr19_-_37427989 | 40.66 |
ENSRNOT00000022863
|
Tppp3
|
tubulin polymerization-promoting protein family member 3 |
chr10_-_56506446 | 36.18 |
ENSRNOT00000021357
|
Acap1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr1_-_142615673 | 34.33 |
ENSRNOT00000018021
|
Iqgap1
|
IQ motif containing GTPase activating protein 1 |
chr4_-_100883038 | 33.62 |
ENSRNOT00000041880
|
LOC100364435
|
thymosin, beta 10-like |
chr4_-_100883275 | 31.83 |
ENSRNOT00000022846
|
LOC100364435
|
thymosin, beta 10-like |
chr13_+_89774764 | 31.79 |
ENSRNOT00000005619
|
Arhgap30
|
Rho GTPase activating protein 30 |
chr6_-_1942972 | 31.60 |
ENSRNOT00000048711
|
Cdc42ep3
|
CDC42 effector protein 3 |
chr14_+_91782354 | 30.06 |
ENSRNOT00000005902
|
Ikzf1
|
IKAROS family zinc finger 1 |
chr7_+_94375020 | 29.30 |
ENSRNOT00000011904
|
Nov
|
nephroblastoma overexpressed |
chr5_+_62840360 | 29.04 |
ENSRNOT00000088385
|
Col15a1
|
collagen type XV alpha 1 chain |
chr13_+_27465930 | 28.72 |
ENSRNOT00000003314
|
Serpinb10
|
serpin family B member 10 |
chr13_-_70626252 | 28.44 |
ENSRNOT00000036947
|
Lamc2
|
laminin subunit gamma 2 |
chr1_-_198128857 | 28.35 |
ENSRNOT00000026496
|
Coro1a
|
coronin 1A |
chr1_+_80321585 | 28.01 |
ENSRNOT00000022895
|
Ckm
|
creatine kinase, M-type |
chr4_+_144382945 | 27.96 |
ENSRNOT00000007601
|
Cav3
|
caveolin 3 |
chr3_+_14467330 | 26.83 |
ENSRNOT00000078939
|
Gsn
|
gelsolin |
chr8_+_44847157 | 26.65 |
ENSRNOT00000080288
|
Clmp
|
CXADR-like membrane protein |
chr3_-_177201525 | 26.26 |
ENSRNOT00000022451
|
Rgs19
|
regulator of G-protein signaling 19 |
chr7_-_70476340 | 25.98 |
ENSRNOT00000006800
|
Arhgef25
|
Rho guanine nucleotide exchange factor 25 |
chr9_+_14529218 | 25.65 |
ENSRNOT00000016893
|
Apobec2
|
apolipoprotein B mRNA editing enzyme catalytic subunit 2 |
chr1_-_47331412 | 25.09 |
ENSRNOT00000046746
|
Ezr
|
ezrin |
chr1_-_145870912 | 24.06 |
ENSRNOT00000016289
|
Il16
|
interleukin 16 |
chr19_+_37235001 | 24.05 |
ENSRNOT00000020908
|
Nol3
|
nucleolar protein 3 |
chr1_-_242765807 | 24.03 |
ENSRNOT00000020763
|
Pgm5
|
phosphoglucomutase 5 |
chrX_+_156463953 | 23.73 |
ENSRNOT00000079889
|
Flna
|
filamin A |
chr4_+_100407658 | 23.59 |
ENSRNOT00000018562
|
Capg
|
capping actin protein, gelsolin like |
chr20_-_5618254 | 23.49 |
ENSRNOT00000092326
ENSRNOT00000000576 |
Bak1
|
BCL2-antagonist/killer 1 |
chr2_+_190007216 | 23.49 |
ENSRNOT00000015612
|
S100a6
|
S100 calcium binding protein A6 |
chr5_+_151413382 | 23.18 |
ENSRNOT00000012626
|
Cd164l2
|
CD164 molecule like 2 |
chr8_+_75687100 | 23.18 |
ENSRNOT00000038677
|
Anxa2
|
annexin A2 |
chr10_-_88036040 | 23.17 |
ENSRNOT00000018851
|
Krt13
|
keratin 13 |
chr2_-_203680083 | 23.13 |
ENSRNOT00000021268
|
Cd2
|
Cd2 molecule |
chr1_+_1180932 | 22.67 |
ENSRNOT00000087443
|
LOC102547056
|
retinoic acid early-inducible protein 1-gamma-like |
chr16_-_36080191 | 22.39 |
ENSRNOT00000017635
|
Hmgb2l1
|
high mobility group box 2-like 1 |
chr1_+_81230612 | 22.37 |
ENSRNOT00000026489
|
Kcnn4
|
potassium calcium-activated channel subfamily N member 4 |
chr2_-_77632628 | 22.10 |
ENSRNOT00000073915
|
Basp1
|
brain abundant, membrane attached signal protein 1 |
chr1_+_168964202 | 22.08 |
ENSRNOT00000089102
|
LOC103694855
|
hemoglobin subunit beta-2-like |
chr3_-_160730360 | 21.86 |
ENSRNOT00000075864
|
RGD1563818
|
similar to secretory leukocyte protease inhibitor |
chr20_-_3401273 | 21.64 |
ENSRNOT00000089257
ENSRNOT00000078451 ENSRNOT00000001085 |
Nrm
|
nurim (nuclear envelope membrane protein) |
chr10_+_48903540 | 21.55 |
ENSRNOT00000004248
|
Trpv2
|
transient receptor potential cation channel, subfamily V, member 2 |
chr1_-_81412251 | 21.20 |
ENSRNOT00000026946
|
Pinlyp
|
phospholipase A2 inhibitor and LY6/PLAUR domain containing |
chr3_-_160802433 | 21.04 |
ENSRNOT00000076191
|
Slpi
|
secretory leukocyte peptidase inhibitor |
chr1_-_89509343 | 20.94 |
ENSRNOT00000028637
|
Fxyd3
|
FXYD domain-containing ion transport regulator 3 |
chr10_-_15590220 | 20.77 |
ENSRNOT00000048977
|
Hba-a2
|
hemoglobin alpha, adult chain 2 |
chr10_+_94566928 | 20.50 |
ENSRNOT00000078446
|
Prr29
|
proline rich 29 |
chr1_-_8751198 | 20.38 |
ENSRNOT00000030511
|
Adgrg6
|
adhesion G protein-coupled receptor G6 |
chr19_-_37970537 | 20.28 |
ENSRNOT00000034722
|
Dpep2
|
dipeptidase 2 |
chr7_-_143837780 | 20.18 |
ENSRNOT00000016642
|
Itgb7
|
integrin subunit beta 7 |
chrX_+_65226748 | 20.11 |
ENSRNOT00000076181
|
Msn
|
moesin |
chr4_+_117744075 | 19.86 |
ENSRNOT00000081173
|
Add2
|
adducin 2 |
chr1_+_168945449 | 19.86 |
ENSRNOT00000087661
ENSRNOT00000019913 |
LOC103694855
|
hemoglobin subunit beta-2-like |
chr17_+_9653561 | 19.84 |
ENSRNOT00000018899
|
Pdlim7
|
PDZ and LIM domain 7 |
chr2_+_209766512 | 19.75 |
ENSRNOT00000092240
|
Kcna3
|
potassium voltage-gated channel subfamily A member 3 |
chr20_-_22004209 | 19.39 |
ENSRNOT00000086250
ENSRNOT00000068778 |
Rtkn2
|
rhotekin 2 |
chr3_+_66193059 | 19.28 |
ENSRNOT00000006880
|
Itga4
|
integrin subunit alpha 4 |
chr1_+_140602542 | 19.24 |
ENSRNOT00000085570
|
Isg20
|
interferon stimulated exonuclease gene 20 |
chr13_-_52197205 | 19.17 |
ENSRNOT00000009712
|
Shisa4
|
shisa family member 4 |
chr14_-_100217913 | 19.10 |
ENSRNOT00000079167
|
Plek
|
pleckstrin |
chr13_+_109713489 | 18.99 |
ENSRNOT00000004962
|
Batf3
|
basic leucine zipper ATF-like transcription factor 3 |
chr5_+_157282669 | 18.98 |
ENSRNOT00000022827
|
Pla2g2a
|
phospholipase A2 group IIA |
chr4_-_150244372 | 18.93 |
ENSRNOT00000047685
|
Ret
|
ret proto-oncogene |
chr5_+_133865331 | 18.73 |
ENSRNOT00000035409
|
Tal1
|
TAL bHLH transcription factor 1, erythroid differentiation factor |
chr5_+_154522119 | 18.72 |
ENSRNOT00000072618
|
E2f2
|
E2F transcription factor 2 |
chr15_-_33629699 | 18.48 |
ENSRNOT00000023302
|
Myh6
|
myosin heavy chain 6 |
chr10_-_15305549 | 18.25 |
ENSRNOT00000027353
|
Pigq
|
phosphatidylinositol glycan anchor biosynthesis, class Q |
chr7_+_70364813 | 18.25 |
ENSRNOT00000084012
ENSRNOT00000031230 |
Agap2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
chr1_-_219532609 | 17.90 |
ENSRNOT00000025641
|
Ankrd13d
|
ankyrin repeat domain 13D |
chr3_-_160739137 | 17.81 |
ENSRNOT00000075836
|
Slpil2
|
antileukoproteinase-like 2 |
chr3_-_160738927 | 17.74 |
ENSRNOT00000043470
|
Slpil2
|
antileukoproteinase-like 2 |
chr1_-_227441442 | 17.61 |
ENSRNOT00000028433
|
Ms4a1
|
membrane spanning 4-domains A1 |
chr2_-_164634434 | 17.58 |
ENSRNOT00000018402
|
Lxn
|
latexin |
chr3_+_103726238 | 17.58 |
ENSRNOT00000006776
|
Lpcat4
|
lysophosphatidylcholine acyltransferase 4 |
chr13_-_47979797 | 17.40 |
ENSRNOT00000080035
|
Rassf5
|
Ras association domain family member 5 |
chr6_-_138093643 | 17.37 |
ENSRNOT00000045874
|
Igh-6
|
immunoglobulin heavy chain 6 |
chr1_-_91074294 | 17.33 |
ENSRNOT00000075236
|
LOC687508
|
similar to Cytochrome c oxidase polypeptide VIIa-heart, mitochondrial precursor (Cytochrome c oxidase subunit VIIa-H) (COX VIIa-M) |
chr3_+_119776925 | 17.32 |
ENSRNOT00000018549
|
Dusp2
|
dual specificity phosphatase 2 |
chr1_-_277181345 | 17.02 |
ENSRNOT00000038017
ENSRNOT00000038038 |
Nrap
|
nebulin-related anchoring protein |
chr1_-_168972725 | 16.93 |
ENSRNOT00000090422
|
Hbb
|
hemoglobin subunit beta |
chr4_-_14490446 | 16.90 |
ENSRNOT00000009132
|
Sema3c
|
semaphorin 3C |
chr14_+_71649274 | 16.86 |
ENSRNOT00000004128
|
Fgfbp1
|
fibroblast growth factor binding protein 1 |
chrX_-_157013443 | 16.84 |
ENSRNOT00000082711
|
Srpk3
|
SRSF protein kinase 3 |
chr16_+_3851270 | 16.82 |
ENSRNOT00000014964
|
Plac9
|
placenta-specific 9 |
chr8_+_59278262 | 16.72 |
ENSRNOT00000017053
|
Dnaja4
|
DnaJ heat shock protein family (Hsp40) member A4 |
chr1_+_40529045 | 16.65 |
ENSRNOT00000026564
|
Mthfd1l
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like |
chr1_+_198528635 | 16.53 |
ENSRNOT00000022765
|
LOC308990
|
hypothetical protein LOC308990 |
chr6_+_137959171 | 16.52 |
ENSRNOT00000006835
|
Crip1
|
cysteine rich protein 1 |
chr6_-_137733026 | 16.49 |
ENSRNOT00000019213
|
Jag2
|
jagged 2 |
chr12_-_30566032 | 16.41 |
ENSRNOT00000093378
|
Gbas
|
glioblastoma amplified sequence |
chrX_-_38196060 | 16.31 |
ENSRNOT00000006741
ENSRNOT00000006438 |
Sh3kbp1
|
SH3 domain-containing kinase-binding protein 1 |
chr7_-_121232741 | 16.30 |
ENSRNOT00000023196
|
Pdgfb
|
platelet derived growth factor subunit B |
chr1_-_101903910 | 16.21 |
ENSRNOT00000028656
|
Emp3
|
epithelial membrane protein 3 |
chr1_+_89215266 | 16.17 |
ENSRNOT00000093612
ENSRNOT00000084799 |
Dmkn
|
dermokine |
chr7_+_120153184 | 16.15 |
ENSRNOT00000013538
|
Lgals1
|
galectin 1 |
chr3_+_123731539 | 16.15 |
ENSRNOT00000051064
|
Cdc25b
|
cell division cycle 25B |
chr19_-_11669578 | 16.08 |
ENSRNOT00000026373
|
Gnao1
|
G protein subunit alpha o1 |
chr1_+_168957460 | 15.85 |
ENSRNOT00000090745
|
LOC103694857
|
hemoglobin subunit beta-2 |
chr1_+_215610368 | 15.79 |
ENSRNOT00000078903
ENSRNOT00000087781 |
Tnni2
|
troponin I2, fast skeletal type |
chr10_-_88874528 | 15.78 |
ENSRNOT00000026783
|
Ptrf
|
polymerase I and transcript release factor |
chr14_+_37113210 | 15.74 |
ENSRNOT00000089094
|
Sgcb
|
sarcoglycan, beta |
chr4_+_109467272 | 15.64 |
ENSRNOT00000008212
|
Reg3b
|
regenerating family member 3 beta |
chr5_+_152681101 | 15.64 |
ENSRNOT00000076052
ENSRNOT00000022574 |
Stmn1
|
stathmin 1 |
chr3_+_11756384 | 15.62 |
ENSRNOT00000087762
|
Sh2d3c
|
SH2 domain containing 3C |
chr19_-_27464805 | 15.62 |
ENSRNOT00000039467
|
Orc6
|
origin recognition complex, subunit 6 |
chr13_-_47154292 | 15.61 |
ENSRNOT00000005284
|
Cd55
|
CD55 molecule, decay accelerating factor for complement |
chr13_-_70625842 | 15.25 |
ENSRNOT00000092499
|
Lamc2
|
laminin subunit gamma 2 |
chr1_-_81627710 | 15.21 |
ENSRNOT00000071704
|
LOC100909700
|
CD177 antigen-like |
chr2_+_193866951 | 15.20 |
ENSRNOT00000013393
|
S100a11
|
S100 calcium binding protein A11 |
chr9_-_10757720 | 15.10 |
ENSRNOT00000083848
|
Uhrf1
|
ubiquitin-like with PHD and ring finger domains 1 |
chr12_-_23624212 | 15.06 |
ENSRNOT00000064405
ENSRNOT00000001943 |
Rasa4
|
RAS p21 protein activator 4 |
chr5_-_58198782 | 14.81 |
ENSRNOT00000023951
|
Ccl21
|
C-C motif chemokine ligand 21 |
chr8_-_58647933 | 14.79 |
ENSRNOT00000038830
|
Tnfaip8l3
|
TNF alpha induced protein 8 like 3 |
chr15_-_29548400 | 14.77 |
ENSRNOT00000078176
|
AABR07017639.2
|
|
chr3_+_111049315 | 14.70 |
ENSRNOT00000017223
|
Spint1
|
serine peptidase inhibitor, Kunitz type 1 |
chr12_-_2438817 | 14.64 |
ENSRNOT00000037059
|
Ccl25
|
C-C motif chemokine ligand 25 |
chr9_+_16702460 | 14.56 |
ENSRNOT00000061432
|
Ptk7
|
protein tyrosine kinase 7 |
chr1_+_134699299 | 14.53 |
ENSRNOT00000068766
|
Rgma
|
repulsive guidance molecule family member A |
chr20_-_3605638 | 14.52 |
ENSRNOT00000074460
|
Sfta2
|
surfactant associated 2 |
chr10_-_40375605 | 14.48 |
ENSRNOT00000014464
|
Anxa6
|
annexin A6 |
chr6_-_139142218 | 14.30 |
ENSRNOT00000006975
|
Ighg
|
Immunoglobulin heavy chain (gamma polypeptide) |
chr1_-_89488223 | 14.24 |
ENSRNOT00000028624
|
Fxyd1
|
FXYD domain-containing ion transport regulator 1 |
chr8_-_116391158 | 14.22 |
ENSRNOT00000078720
ENSRNOT00000022550 |
Gnai2
|
G protein subunit alpha i2 |
chr5_-_59025631 | 14.11 |
ENSRNOT00000049000
ENSRNOT00000022801 |
Tpm2
|
tropomyosin 2, beta |
chr9_-_14668297 | 14.03 |
ENSRNOT00000042404
|
Treml2
|
triggering receptor expressed on myeloid cells-like 2 |
chr16_-_81243757 | 14.02 |
ENSRNOT00000024677
|
Gas6
|
growth arrest specific 6 |
chr4_+_117743710 | 13.90 |
ENSRNOT00000021491
|
Add2
|
adducin 2 |
chr5_-_152358643 | 13.88 |
ENSRNOT00000021734
|
Sh3bgrl3
|
SH3 domain binding glutamate-rich protein like 3 |
chr2_+_206064394 | 13.86 |
ENSRNOT00000077739
|
Syt6
|
synaptotagmin 6 |
chr3_-_60105212 | 13.78 |
ENSRNOT00000086329
ENSRNOT00000025158 |
Gpr155
|
G protein-coupled receptor 155 |
chr5_-_151459037 | 13.74 |
ENSRNOT00000064472
ENSRNOT00000087836 |
Sytl1
|
synaptotagmin-like 1 |
chr10_+_89251370 | 13.74 |
ENSRNOT00000076820
|
Aoc3
|
amine oxidase, copper containing 3 |
chrX_-_32355296 | 13.69 |
ENSRNOT00000081652
ENSRNOT00000065075 |
Ap1s2
|
adaptor-related protein complex 1, sigma 2 subunit |
chr14_-_45165207 | 13.68 |
ENSRNOT00000002960
|
Klf3
|
Kruppel like factor 3 |
chr16_+_2958283 | 13.67 |
ENSRNOT00000019511
|
Arhgef3
|
Rho guanine nucleotide exchange factor 3 |
chr1_-_142183884 | 13.60 |
ENSRNOT00000016032
|
Fes
|
FES proto-oncogene, tyrosine kinase |
chr1_+_39811314 | 13.56 |
ENSRNOT00000022046
|
Ppp1r14c
|
protein phosphatase 1, regulatory (inhibitor) subunit 14c |
chr19_+_26016382 | 13.29 |
ENSRNOT00000004601
|
Klf1
|
Kruppel like factor 1 |
chr1_-_101236065 | 13.16 |
ENSRNOT00000066834
|
Cd37
|
CD37 molecule |
chr7_-_119797098 | 13.12 |
ENSRNOT00000009994
|
Rac2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr10_-_82785142 | 13.09 |
ENSRNOT00000005381
|
Sgca
|
sarcoglycan, alpha |
chr5_-_72287669 | 13.06 |
ENSRNOT00000022255
|
Klf4
|
Kruppel like factor 4 |
chr1_+_215609645 | 13.02 |
ENSRNOT00000076140
ENSRNOT00000027487 |
Tnni2
|
troponin I2, fast skeletal type |
chr16_+_8128689 | 13.01 |
ENSRNOT00000065618
|
Galnt15
|
polypeptide N-acetylgalactosaminyltransferase 15 |
chr18_-_11789697 | 12.94 |
ENSRNOT00000077304
ENSRNOT00000064554 |
Dsc3
|
desmocollin 3 |
chr16_-_64778486 | 12.92 |
ENSRNOT00000031701
|
Rnf122
|
ring finger protein 122 |
chr10_+_70262361 | 12.92 |
ENSRNOT00000064625
ENSRNOT00000076973 |
Unc45b
|
unc-45 myosin chaperone B |
chr19_-_55490426 | 12.80 |
ENSRNOT00000081800
|
Cbfa2t3
|
CBFA2/RUNX1 translocation partner 3 |
chr5_+_152533349 | 12.76 |
ENSRNOT00000067524
|
Trim63
|
tripartite motif containing 63 |
chr8_+_11931767 | 12.74 |
ENSRNOT00000087963
|
Maml2
|
mastermind-like transcriptional coactivator 2 |
chr20_-_4863011 | 12.65 |
ENSRNOT00000079503
|
Ltb
|
lymphotoxin beta |
chr19_+_37568113 | 12.65 |
ENSRNOT00000023710
|
Fam65a
|
family with sequence similarity 65, member A |
chr2_+_95320283 | 12.62 |
ENSRNOT00000015537
|
Hey1
|
hes-related family bHLH transcription factor with YRPW motif 1 |
chr9_+_9970209 | 12.56 |
ENSRNOT00000075215
|
Dennd1c
|
DENN/MADD domain containing 1C |
chr11_+_61083757 | 12.50 |
ENSRNOT00000002790
|
Boc
|
BOC cell adhesion associated, oncogene regulated |
chr1_+_142087208 | 12.46 |
ENSRNOT00000017532
|
Prc1
|
protein regulator of cytokinesis 1 |
chr1_+_29191192 | 12.30 |
ENSRNOT00000018718
|
Hey2
|
hes-related family bHLH transcription factor with YRPW motif 2 |
chr10_-_14022452 | 12.28 |
ENSRNOT00000016554
|
Npw
|
neuropeptide W |
chr10_-_4644570 | 12.20 |
ENSRNOT00000088279
|
Snn
|
stannin |
chr1_+_226091774 | 12.20 |
ENSRNOT00000027693
|
Fads3
|
fatty acid desaturase 3 |
chr8_+_99977334 | 12.19 |
ENSRNOT00000085808
ENSRNOT00000056704 ENSRNOT00000041859 |
Plod2
|
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
chr8_-_50228369 | 12.16 |
ENSRNOT00000024030
|
Tagln
|
transgelin |
chr10_-_56962161 | 12.14 |
ENSRNOT00000026038
|
Alox15
|
arachidonate 15-lipoxygenase |
chrX_+_138046494 | 12.12 |
ENSRNOT00000010596
|
Stk26
|
serine/threonine kinase 26 |
chr1_-_82610350 | 11.98 |
ENSRNOT00000028177
|
Cyp2s1
|
cytochrome P450, family 2, subfamily s, polypeptide 1 |
chr20_+_44521279 | 11.96 |
ENSRNOT00000085987
|
Fyn
|
FYN proto-oncogene, Src family tyrosine kinase |
chr6_+_132510757 | 11.95 |
ENSRNOT00000080230
|
Evl
|
Enah/Vasp-like |
chr1_+_178351680 | 11.91 |
ENSRNOT00000018532
ENSRNOT00000076925 ENSRNOT00000076430 ENSRNOT00000076756 |
Far1
|
fatty acyl CoA reductase 1 |
chr1_-_84145916 | 11.84 |
ENSRNOT00000081796
|
Ltbp4
|
latent transforming growth factor beta binding protein 4 |
chr4_+_78320190 | 11.70 |
ENSRNOT00000032742
ENSRNOT00000091359 |
Gimap4
|
GTPase, IMAP family member 4 |
chr5_+_169288871 | 11.69 |
ENSRNOT00000055466
|
Tnfrsf25
|
TNF receptor superfamily member 25 |
chr10_-_15577977 | 11.67 |
ENSRNOT00000052292
|
Hba-a3
|
hemoglobin alpha, adult chain 3 |
chr4_+_155321553 | 11.64 |
ENSRNOT00000089614
|
Mfap5
|
microfibrillar associated protein 5 |
chr19_-_55510460 | 11.61 |
ENSRNOT00000019820
|
Cbfa2t3
|
CBFA2/RUNX1 translocation partner 3 |
chr19_+_24846938 | 11.60 |
ENSRNOT00000045974
|
Ddx39a
|
DExD-box helicase 39A |
chr1_+_105349069 | 11.60 |
ENSRNOT00000056030
|
Nell1
|
neural EGFL like 1 |
chr8_+_5768811 | 11.57 |
ENSRNOT00000013936
|
Mmp8
|
matrix metallopeptidase 8 |
chr5_+_64476317 | 11.57 |
ENSRNOT00000017217
|
LOC108348074
|
collagen alpha-1(XV) chain-like |
chr17_-_68559471 | 11.55 |
ENSRNOT00000023252
|
Pfkp
|
phosphofructokinase, platelet |
chr8_+_64481172 | 11.54 |
ENSRNOT00000015332
|
Pkm
|
pyruvate kinase, muscle |
chr4_+_99185885 | 11.53 |
ENSRNOT00000009392
|
Cd8b
|
CD8b molecule |
chr9_+_37727942 | 11.53 |
ENSRNOT00000016511
ENSRNOT00000074276 |
LOC100912306
|
myotilin-like |
chr10_+_91254058 | 11.43 |
ENSRNOT00000087218
ENSRNOT00000065373 |
Fmnl1
|
formin-like 1 |
chr1_+_31967978 | 11.30 |
ENSRNOT00000081471
ENSRNOT00000021532 |
Trip13
|
thyroid hormone receptor interactor 13 |
chr6_-_142903440 | 11.28 |
ENSRNOT00000075707
|
AABR07065823.2
|
|
chr1_-_220136470 | 11.24 |
ENSRNOT00000026812
|
Actn3
|
actinin alpha 3 |
chr15_+_24153602 | 11.22 |
ENSRNOT00000014216
|
Lgals3
|
galectin 3 |
chr12_+_49761120 | 11.20 |
ENSRNOT00000070961
|
Myo18b
|
myosin XVIIIb |
chr1_-_100669684 | 11.17 |
ENSRNOT00000091760
|
Myh14
|
myosin heavy chain 14 |
chr4_+_168832910 | 11.14 |
ENSRNOT00000011134
|
Gprc5a
|
G protein-coupled receptor, class C, group 5, member A |
chr1_+_85386470 | 11.13 |
ENSRNOT00000093332
ENSRNOT00000044326 |
Plekhg2
|
pleckstrin homology and RhoGEF domain containing G2 |
chr17_-_47394231 | 11.11 |
ENSRNOT00000079368
ENSRNOT00000079216 |
Sfrp4
|
secreted frizzled-related protein 4 |
chr10_-_87067456 | 11.10 |
ENSRNOT00000014163
|
Ccr7
|
C-C motif chemokine receptor 7 |
chr20_+_5509059 | 11.09 |
ENSRNOT00000065349
|
Kifc1
|
kinesin family member C1 |
chr1_-_100671074 | 11.07 |
ENSRNOT00000027132
|
Myh14
|
myosin heavy chain 14 |
chr7_-_118840634 | 11.04 |
ENSRNOT00000031568
|
Apol11a
|
apolipoprotein L 11a |
chr15_+_110114148 | 10.97 |
ENSRNOT00000006264
|
Itgbl1
|
integrin subunit beta like 1 |
chr1_-_7064870 | 10.97 |
ENSRNOT00000019983
|
Stx11
|
syntaxin 11 |
chr8_+_116686601 | 10.95 |
ENSRNOT00000066104
|
Mst1r
|
macrophage stimulating 1 receptor |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.7 | 44.0 | GO:0002432 | granuloma formation(GO:0002432) |
9.8 | 29.3 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) negative regulation of sensory perception of pain(GO:1904057) |
9.7 | 29.1 | GO:0045799 | positive regulation of chromatin assembly or disassembly(GO:0045799) |
9.6 | 38.6 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
8.3 | 24.9 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
8.0 | 24.1 | GO:0014736 | negative regulation of muscle atrophy(GO:0014736) |
7.7 | 23.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
7.7 | 23.2 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
7.5 | 45.2 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
7.5 | 30.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
7.1 | 42.5 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
7.1 | 49.5 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
7.0 | 105.0 | GO:0015671 | oxygen transport(GO:0015671) |
7.0 | 28.0 | GO:0035995 | detection of muscle stretch(GO:0035995) positive regulation of caveolin-mediated endocytosis(GO:2001288) |
6.9 | 34.3 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
6.6 | 13.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
6.5 | 26.1 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
6.4 | 19.2 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
6.4 | 25.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
6.3 | 12.6 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
6.2 | 18.5 | GO:1905242 | response to 3,3',5-triiodo-L-thyronine(GO:1905242) cellular response to 3,3',5-triiodo-L-thyronine(GO:1905243) |
6.2 | 6.2 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
6.1 | 30.3 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
5.6 | 16.7 | GO:0015942 | formate metabolic process(GO:0015942) |
5.0 | 19.9 | GO:0070560 | protein secretion by platelet(GO:0070560) |
4.8 | 19.3 | GO:0050904 | diapedesis(GO:0050904) |
4.8 | 14.3 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
4.7 | 23.7 | GO:1905031 | regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905031) |
4.7 | 4.7 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
4.5 | 27.0 | GO:0048597 | B cell selection(GO:0002339) post-embryonic camera-type eye morphogenesis(GO:0048597) |
4.5 | 22.3 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
4.4 | 17.5 | GO:1903575 | cornified envelope assembly(GO:1903575) |
4.4 | 39.3 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
4.3 | 17.4 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
4.3 | 21.5 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
4.3 | 34.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
4.2 | 16.9 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
4.2 | 12.7 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
4.1 | 12.2 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
4.0 | 48.5 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
3.9 | 15.6 | GO:1903576 | response to L-arginine(GO:1903576) |
3.8 | 11.4 | GO:0002488 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
3.8 | 22.8 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
3.6 | 14.2 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
3.5 | 17.6 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
3.4 | 10.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
3.4 | 20.6 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
3.4 | 6.7 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
3.4 | 43.7 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
3.3 | 13.2 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
3.3 | 16.5 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
3.3 | 65.6 | GO:0070831 | basement membrane assembly(GO:0070831) |
3.3 | 9.8 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
3.2 | 9.7 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
3.2 | 16.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
3.2 | 9.7 | GO:0021678 | third ventricle development(GO:0021678) |
3.2 | 12.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
3.0 | 9.1 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
3.0 | 9.0 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
3.0 | 24.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
2.9 | 8.8 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
2.9 | 8.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
2.9 | 31.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
2.9 | 31.4 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
2.8 | 11.4 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
2.8 | 14.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
2.8 | 25.4 | GO:0043587 | tongue morphogenesis(GO:0043587) |
2.8 | 8.5 | GO:0043474 | eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) rhodopsin metabolic process(GO:0046154) |
2.8 | 16.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
2.8 | 5.5 | GO:0030221 | basophil differentiation(GO:0030221) |
2.8 | 13.9 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
2.7 | 60.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
2.7 | 8.2 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
2.7 | 21.7 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
2.7 | 5.3 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
2.7 | 8.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
2.6 | 5.2 | GO:0070268 | cornification(GO:0070268) |
2.6 | 7.7 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
2.6 | 23.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
2.5 | 7.6 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
2.5 | 7.5 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
2.5 | 24.6 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
2.4 | 7.2 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
2.4 | 28.9 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
2.4 | 14.3 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
2.4 | 9.5 | GO:0034436 | glycoprotein transport(GO:0034436) |
2.4 | 7.1 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
2.4 | 11.8 | GO:1904717 | regulation of AMPA glutamate receptor clustering(GO:1904717) |
2.3 | 4.7 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
2.3 | 2.3 | GO:1903796 | negative regulation of inorganic anion transmembrane transport(GO:1903796) |
2.3 | 9.0 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
2.2 | 11.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
2.2 | 2.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
2.2 | 13.1 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
2.2 | 6.5 | GO:0051012 | microtubule sliding(GO:0051012) |
2.2 | 6.5 | GO:1901558 | response to metformin(GO:1901558) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
2.2 | 6.5 | GO:2001106 | fasciculation of motor neuron axon(GO:0097156) regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
2.2 | 6.5 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
2.2 | 6.5 | GO:0010265 | SCF complex assembly(GO:0010265) |
2.1 | 34.3 | GO:0014870 | response to muscle inactivity(GO:0014870) |
2.1 | 10.5 | GO:0060486 | Clara cell differentiation(GO:0060486) |
2.1 | 6.3 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
2.1 | 6.3 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
2.1 | 8.3 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
2.1 | 8.2 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
2.1 | 16.5 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
2.1 | 6.2 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
2.0 | 4.0 | GO:1905007 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905007) |
2.0 | 6.0 | GO:2000660 | negative regulation of chemokine biosynthetic process(GO:0045079) negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
2.0 | 10.0 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
2.0 | 13.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
2.0 | 11.9 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
2.0 | 23.7 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
2.0 | 5.9 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
1.9 | 5.8 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.9 | 5.8 | GO:0072237 | metanephric proximal tubule development(GO:0072237) |
1.9 | 9.6 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
1.9 | 13.4 | GO:0007144 | female meiosis I(GO:0007144) |
1.9 | 9.5 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.9 | 9.5 | GO:0080154 | regulation of fertilization(GO:0080154) |
1.9 | 11.2 | GO:0051014 | actin filament severing(GO:0051014) |
1.9 | 22.4 | GO:0006265 | DNA topological change(GO:0006265) |
1.9 | 13.0 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
1.8 | 7.3 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
1.8 | 5.5 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
1.8 | 9.0 | GO:1900194 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
1.8 | 7.2 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
1.8 | 5.3 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
1.8 | 5.3 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
1.7 | 3.5 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
1.7 | 31.2 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
1.7 | 6.8 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
1.7 | 5.1 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
1.7 | 5.1 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
1.7 | 3.4 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
1.7 | 8.3 | GO:0090131 | mesenchyme migration(GO:0090131) |
1.6 | 9.8 | GO:0090166 | Golgi disassembly(GO:0090166) |
1.6 | 6.5 | GO:0006272 | leading strand elongation(GO:0006272) |
1.6 | 6.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.6 | 8.1 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
1.6 | 4.9 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.6 | 11.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.6 | 11.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
1.6 | 4.8 | GO:0060594 | mammary gland specification(GO:0060594) |
1.6 | 4.8 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.6 | 20.5 | GO:0006527 | arginine catabolic process(GO:0006527) |
1.6 | 9.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.6 | 6.2 | GO:0072014 | proximal tubule development(GO:0072014) |
1.5 | 7.7 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
1.5 | 9.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
1.5 | 30.3 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
1.5 | 13.6 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
1.5 | 4.4 | GO:1902412 | positive regulation of centriole replication(GO:0046601) regulation of mitotic cytokinesis(GO:1902412) |
1.5 | 8.9 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
1.4 | 13.0 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
1.4 | 15.9 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
1.4 | 4.3 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
1.4 | 7.2 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
1.4 | 7.1 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) |
1.4 | 4.3 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) regulation of bleb assembly(GO:1904170) |
1.4 | 14.2 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
1.4 | 2.8 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
1.4 | 5.6 | GO:0098886 | modification of dendritic spine(GO:0098886) |
1.4 | 4.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
1.4 | 16.6 | GO:0030913 | paranodal junction assembly(GO:0030913) |
1.4 | 12.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.4 | 24.7 | GO:0032816 | positive regulation of natural killer cell activation(GO:0032816) |
1.4 | 8.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.4 | 2.7 | GO:0030186 | melatonin metabolic process(GO:0030186) |
1.4 | 2.7 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
1.4 | 8.1 | GO:0021633 | optic nerve structural organization(GO:0021633) |
1.4 | 8.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.3 | 9.4 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
1.3 | 8.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
1.3 | 9.4 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
1.3 | 14.6 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
1.3 | 5.2 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
1.3 | 1.3 | GO:0021997 | neural plate axis specification(GO:0021997) |
1.3 | 1.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
1.3 | 5.1 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
1.3 | 10.1 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
1.3 | 8.8 | GO:0071681 | cellular response to indole-3-methanol(GO:0071681) |
1.3 | 3.8 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
1.2 | 7.4 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.2 | 17.3 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
1.2 | 8.6 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.2 | 3.7 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
1.2 | 1.2 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
1.2 | 6.0 | GO:0033623 | regulation of integrin activation(GO:0033623) |
1.2 | 7.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.2 | 5.9 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
1.2 | 4.7 | GO:0070459 | prolactin secretion(GO:0070459) |
1.2 | 5.9 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
1.2 | 23.4 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
1.2 | 5.8 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
1.2 | 4.7 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.2 | 5.8 | GO:0035617 | stress granule disassembly(GO:0035617) |
1.2 | 8.1 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
1.1 | 5.7 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
1.1 | 13.7 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
1.1 | 5.7 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.1 | 3.4 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling(GO:0060683) embryonic lung development(GO:1990401) |
1.1 | 3.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.1 | 11.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
1.1 | 3.4 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
1.1 | 6.7 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
1.1 | 5.5 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
1.1 | 7.7 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
1.1 | 31.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
1.1 | 45.8 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
1.1 | 12.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
1.1 | 4.3 | GO:1900224 | zygotic specification of dorsal/ventral axis(GO:0007352) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
1.1 | 18.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.1 | 4.2 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
1.1 | 2.1 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
1.0 | 3.1 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
1.0 | 24.0 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
1.0 | 3.1 | GO:0060383 | positive regulation of DNA strand elongation(GO:0060383) |
1.0 | 6.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.0 | 2.1 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
1.0 | 2.1 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
1.0 | 10.4 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
1.0 | 11.4 | GO:0086027 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
1.0 | 17.6 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
1.0 | 6.2 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
1.0 | 3.1 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
1.0 | 3.0 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
1.0 | 3.0 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
1.0 | 4.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
1.0 | 8.0 | GO:0006751 | glutathione catabolic process(GO:0006751) |
1.0 | 7.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
1.0 | 15.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
1.0 | 9.6 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
1.0 | 2.9 | GO:0015820 | leucine transport(GO:0015820) |
0.9 | 3.8 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.9 | 8.5 | GO:0002467 | germinal center formation(GO:0002467) |
0.9 | 22.5 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.9 | 2.8 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.9 | 0.9 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.9 | 13.9 | GO:0032060 | bleb assembly(GO:0032060) |
0.9 | 4.6 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.9 | 1.8 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.9 | 4.6 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.9 | 4.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.9 | 11.7 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.9 | 1.8 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.9 | 22.2 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.9 | 2.6 | GO:0051305 | mitotic chromosome movement towards spindle pole(GO:0007079) chromosome movement towards spindle pole(GO:0051305) |
0.9 | 4.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.9 | 3.5 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
0.9 | 0.9 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.9 | 5.2 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.9 | 16.4 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.9 | 5.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.9 | 6.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.8 | 10.1 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.8 | 9.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.8 | 2.5 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.8 | 2.5 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.8 | 6.6 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.8 | 3.3 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.8 | 2.5 | GO:0036446 | myofibroblast differentiation(GO:0036446) cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) regulation of myofibroblast differentiation(GO:1904760) |
0.8 | 1.6 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.8 | 4.1 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.8 | 29.0 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.8 | 9.7 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.8 | 5.6 | GO:0009405 | pathogenesis(GO:0009405) |
0.8 | 0.8 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.8 | 1.6 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.8 | 17.5 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.8 | 1.6 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.8 | 2.4 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.8 | 3.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.8 | 5.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.8 | 2.4 | GO:1990790 | response to glial cell derived neurotrophic factor(GO:1990790) cellular response to glial cell derived neurotrophic factor(GO:1990792) |
0.8 | 15.6 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.8 | 5.4 | GO:0060736 | prostate gland growth(GO:0060736) |
0.8 | 1.6 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.8 | 24.3 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.8 | 12.1 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.8 | 6.0 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.8 | 2.3 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.7 | 12.6 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
0.7 | 3.7 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.7 | 21.3 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
0.7 | 5.8 | GO:0050957 | equilibrioception(GO:0050957) |
0.7 | 2.9 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.7 | 2.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.7 | 9.4 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.7 | 8.6 | GO:0032324 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.7 | 19.9 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.7 | 4.9 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.7 | 3.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.7 | 5.4 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.7 | 3.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.7 | 2.7 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.7 | 10.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.7 | 11.2 | GO:0019532 | oxalate transport(GO:0019532) sulfate transmembrane transport(GO:1902358) |
0.6 | 1.9 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.6 | 4.5 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.6 | 13.6 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.6 | 2.6 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.6 | 10.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 3.8 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.6 | 3.8 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.6 | 0.6 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.6 | 1.9 | GO:0071623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
0.6 | 1.9 | GO:0019046 | viral latency(GO:0019042) release from viral latency(GO:0019046) |
0.6 | 3.7 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
0.6 | 6.9 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.6 | 3.1 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.6 | 6.8 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.6 | 2.5 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.6 | 1.8 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.6 | 1.8 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.6 | 5.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.6 | 6.7 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.6 | 4.3 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.6 | 4.2 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.6 | 3.6 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.6 | 1.8 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.6 | 3.6 | GO:0034184 | positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.6 | 9.5 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.6 | 11.8 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.6 | 11.7 | GO:0097435 | fibril organization(GO:0097435) |
0.6 | 4.1 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.6 | 1.7 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.6 | 2.9 | GO:0071035 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear retention of pre-mRNA at the site of transcription(GO:0071033) CUT catabolic process(GO:0071034) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) CUT metabolic process(GO:0071043) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
0.6 | 4.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.6 | 3.4 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.6 | 7.4 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.6 | 1.7 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.6 | 7.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.6 | 6.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.6 | 2.8 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.6 | 2.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.6 | 2.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.5 | 1.1 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.5 | 2.7 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.5 | 3.8 | GO:0016322 | neuron remodeling(GO:0016322) |
0.5 | 5.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.5 | 8.0 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.5 | 11.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.5 | 6.8 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.5 | 15.2 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.5 | 2.6 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.5 | 8.3 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.5 | 2.6 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.5 | 4.7 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.5 | 1.0 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.5 | 2.6 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.5 | 3.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.5 | 4.5 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.5 | 8.6 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.5 | 6.0 | GO:0097205 | renal filtration(GO:0097205) |
0.5 | 1.5 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.5 | 5.0 | GO:0007520 | myoblast fusion(GO:0007520) |
0.5 | 19.1 | GO:0008542 | visual learning(GO:0008542) |
0.5 | 1.0 | GO:0071442 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.5 | 2.9 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.5 | 12.4 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.5 | 1.9 | GO:0042891 | antibiotic transport(GO:0042891) |
0.5 | 1.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.5 | 5.2 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.5 | 2.8 | GO:0050917 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) sensory perception of umami taste(GO:0050917) |
0.5 | 2.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.5 | 12.1 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.5 | 0.9 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.5 | 2.8 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.5 | 2.3 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.5 | 2.3 | GO:0071373 | cellular response to luteinizing hormone stimulus(GO:0071373) |
0.5 | 1.8 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.5 | 0.9 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.5 | 1.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.5 | 7.7 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.5 | 4.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.5 | 4.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 6.3 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.4 | 5.3 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.4 | 5.8 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.4 | 11.0 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.4 | 10.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.4 | 9.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.4 | 2.2 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.4 | 1.8 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.4 | 16.2 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.4 | 3.0 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.4 | 7.0 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.4 | 5.2 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.4 | 1.3 | GO:0051697 | protein delipidation(GO:0051697) |
0.4 | 1.7 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.4 | 0.4 | GO:0040031 | snRNA modification(GO:0040031) |
0.4 | 11.6 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.4 | 2.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.4 | 3.0 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.4 | 8.4 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.4 | 9.2 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.4 | 8.8 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.4 | 8.3 | GO:1903205 | regulation of hydrogen peroxide-induced cell death(GO:1903205) |
0.4 | 1.2 | GO:0016240 | autophagosome docking(GO:0016240) |
0.4 | 6.6 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.4 | 1.2 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
0.4 | 7.8 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.4 | 2.4 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.4 | 0.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 7.3 | GO:0032274 | gonadotropin secretion(GO:0032274) |
0.4 | 0.8 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.4 | 4.3 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) |
0.4 | 13.7 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.4 | 6.6 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.4 | 0.8 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.4 | 1.2 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.4 | 7.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.4 | 3.1 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
0.4 | 3.4 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.4 | 6.1 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.4 | 9.1 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.4 | 2.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.4 | 8.3 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.4 | 168.5 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.4 | 6.8 | GO:0097503 | sialylation(GO:0097503) |
0.4 | 4.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 3.4 | GO:0021707 | cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.4 | 1.9 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.4 | 1.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.4 | 1.5 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.4 | 13.7 | GO:0070527 | platelet aggregation(GO:0070527) |
0.4 | 1.5 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.4 | 3.6 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.4 | 1.4 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.4 | 3.2 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.4 | 5.7 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.4 | 8.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.4 | 1.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.3 | 0.7 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.3 | 2.8 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.3 | 3.4 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.3 | 3.1 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.3 | 0.7 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) regulation of interleukin-1 alpha secretion(GO:0050705) positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.3 | 5.1 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.3 | 9.5 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.3 | 11.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.3 | 2.7 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.3 | 1.7 | GO:0070986 | left/right axis specification(GO:0070986) |
0.3 | 7.3 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.3 | 1.0 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 2.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 5.9 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.3 | 13.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.3 | 3.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 1.9 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.3 | 3.8 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.3 | 4.7 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.3 | 5.7 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.3 | 1.6 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.3 | 4.4 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.3 | 2.8 | GO:0001967 | suckling behavior(GO:0001967) |
0.3 | 2.7 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.3 | 9.7 | GO:0048286 | lung alveolus development(GO:0048286) |
0.3 | 1.5 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.3 | 10.2 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.3 | 8.7 | GO:0090307 | mitotic spindle assembly(GO:0090307) |
0.3 | 7.2 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.3 | 1.2 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.3 | 4.7 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.3 | 0.6 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.3 | 3.2 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.3 | 9.6 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.3 | 1.2 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.3 | 11.8 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.3 | 1.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 4.8 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.3 | 0.8 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.3 | 1.1 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.3 | 2.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.3 | 15.6 | GO:0009408 | response to heat(GO:0009408) |
0.3 | 9.8 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.3 | 11.7 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.3 | 3.7 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.3 | 4.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.3 | 3.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.3 | 2.3 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.3 | 0.5 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.3 | 0.8 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) positive regulation of polyamine transmembrane transport(GO:1902269) |
0.3 | 1.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.3 | 6.5 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.2 | 1.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 2.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 1.2 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.2 | 1.4 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 2.4 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.2 | 0.7 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 2.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.2 | 7.7 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 3.0 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.2 | 0.7 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 1.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 5.2 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 7.2 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.2 | 9.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.2 | 1.5 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 3.0 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 2.7 | GO:0043489 | RNA stabilization(GO:0043489) |
0.2 | 2.7 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.2 | 0.6 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.2 | 1.0 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.2 | 1.8 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.2 | 2.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.2 | 6.4 | GO:0032418 | lysosome localization(GO:0032418) |
0.2 | 6.3 | GO:0006414 | translational elongation(GO:0006414) |
0.2 | 3.7 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.2 | 2.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 2.8 | GO:0031572 | mitotic G2 DNA damage checkpoint(GO:0007095) G2 DNA damage checkpoint(GO:0031572) |
0.2 | 7.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 5.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 1.9 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.2 | 4.6 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 0.4 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.2 | 14.7 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.2 | 0.9 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.2 | 4.7 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.2 | 3.6 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 3.3 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.2 | 1.3 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.2 | 2.4 | GO:0070166 | enamel mineralization(GO:0070166) |
0.2 | 7.4 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.2 | 2.0 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.2 | 0.3 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.2 | 1.5 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.1 | 0.7 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 1.5 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 1.7 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.1 | 5.2 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.1 | 0.4 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 0.8 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 1.9 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 5.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.8 | GO:1903306 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) negative regulation of regulated secretory pathway(GO:1903306) |
0.1 | 1.8 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 4.1 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.1 | 1.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 1.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 5.2 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 6.9 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.1 | 0.7 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 1.6 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 1.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 1.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 1.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.6 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.8 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 2.4 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 3.9 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 0.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.3 | GO:0044691 | tooth eruption(GO:0044691) |
0.1 | 2.6 | GO:0032609 | interferon-gamma production(GO:0032609) |
0.1 | 0.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 1.9 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 2.9 | GO:0048512 | circadian behavior(GO:0048512) |
0.1 | 1.7 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.1 | 1.5 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 0.8 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 4.8 | GO:0050821 | protein stabilization(GO:0050821) |
0.1 | 4.9 | GO:0007631 | feeding behavior(GO:0007631) |
0.1 | 1.6 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 1.7 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.9 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.7 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 0.7 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.4 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.1 | 1.9 | GO:0021762 | substantia nigra development(GO:0021762) |
0.1 | 0.1 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.1 | 0.8 | GO:0030728 | ovulation(GO:0030728) |
0.1 | 1.4 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.4 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 0.5 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 0.1 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.3 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.1 | GO:0070637 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.0 | 0.9 | GO:1990089 | response to nerve growth factor(GO:1990089) |
0.0 | 0.0 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.0 | 0.4 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.0 | 0.9 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.0 | 0.3 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.1 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 5.0 | GO:0070489 | T cell activation(GO:0042110) T cell aggregation(GO:0070489) |
0.0 | 0.5 | GO:0090382 | phagosome maturation(GO:0090382) |
0.0 | 0.3 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.5 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.3 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 1.8 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 1.3 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.2 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.3 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.8 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 1.6 | GO:0009615 | response to virus(GO:0009615) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.1 | 44.3 | GO:0005607 | laminin-2 complex(GO:0005607) |
9.5 | 105.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
8.0 | 31.9 | GO:0097513 | myosin II filament(GO:0097513) |
7.9 | 31.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
7.3 | 44.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
6.3 | 25.1 | GO:0036398 | TCR signalosome(GO:0036398) microspike(GO:0044393) |
4.8 | 28.8 | GO:0016012 | sarcoglycan complex(GO:0016012) |
4.6 | 13.9 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
4.5 | 26.8 | GO:0030478 | actin cap(GO:0030478) |
3.9 | 27.4 | GO:0090543 | Flemming body(GO:0090543) |
3.7 | 37.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
3.6 | 47.2 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
3.4 | 24.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
3.4 | 13.6 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
3.4 | 13.5 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
3.3 | 39.7 | GO:0005861 | troponin complex(GO:0005861) |
3.2 | 9.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
3.0 | 3.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
2.8 | 16.9 | GO:0005608 | laminin-3 complex(GO:0005608) |
2.7 | 8.2 | GO:1902560 | GMP reductase complex(GO:1902560) |
2.7 | 24.3 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
2.7 | 13.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
2.7 | 21.2 | GO:0032584 | growth cone membrane(GO:0032584) |
2.6 | 7.8 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
2.6 | 7.7 | GO:1990423 | RZZ complex(GO:1990423) |
2.4 | 26.8 | GO:0032982 | myosin filament(GO:0032982) |
2.4 | 7.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
2.4 | 7.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
2.2 | 2.2 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
2.1 | 32.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
2.0 | 20.1 | GO:0051286 | cell tip(GO:0051286) |
2.0 | 6.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
2.0 | 6.0 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
1.9 | 5.8 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
1.9 | 5.8 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
1.9 | 5.6 | GO:0097444 | spine apparatus(GO:0097444) |
1.8 | 9.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
1.8 | 7.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.7 | 15.6 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.7 | 8.4 | GO:0034455 | t-UTP complex(GO:0034455) |
1.6 | 4.9 | GO:0035101 | FACT complex(GO:0035101) |
1.6 | 17.9 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
1.6 | 14.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.6 | 11.0 | GO:0000796 | condensin complex(GO:0000796) |
1.5 | 6.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.5 | 13.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.5 | 5.8 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
1.4 | 13.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
1.4 | 7.2 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.4 | 53.4 | GO:0001772 | immunological synapse(GO:0001772) |
1.4 | 15.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
1.4 | 15.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.4 | 4.1 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
1.4 | 9.5 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.3 | 6.7 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.3 | 6.5 | GO:0005940 | septin ring(GO:0005940) |
1.3 | 20.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.3 | 6.4 | GO:0098845 | postsynaptic endosome(GO:0098845) |
1.3 | 6.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
1.3 | 34.0 | GO:0031430 | M band(GO:0031430) |
1.3 | 3.8 | GO:0032398 | MHC class Ib protein complex(GO:0032398) |
1.2 | 12.5 | GO:0070938 | contractile ring(GO:0070938) |
1.2 | 1.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
1.2 | 36.2 | GO:0008305 | integrin complex(GO:0008305) |
1.2 | 4.8 | GO:0034657 | GID complex(GO:0034657) |
1.2 | 5.9 | GO:0043293 | apoptosome(GO:0043293) |
1.2 | 15.2 | GO:0000124 | SAGA complex(GO:0000124) |
1.2 | 5.8 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
1.1 | 13.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.1 | 11.2 | GO:0042587 | glycogen granule(GO:0042587) |
1.1 | 5.6 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
1.1 | 5.5 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
1.1 | 12.0 | GO:0044327 | dendritic spine head(GO:0044327) |
1.1 | 5.4 | GO:0035061 | interchromatin granule(GO:0035061) |
1.1 | 4.3 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
1.1 | 79.0 | GO:0031902 | late endosome membrane(GO:0031902) |
1.1 | 7.5 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
1.1 | 1.1 | GO:0000346 | transcription export complex(GO:0000346) |
1.1 | 4.3 | GO:0031592 | centrosomal corona(GO:0031592) |
1.1 | 7.4 | GO:0008091 | spectrin(GO:0008091) |
1.1 | 12.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
1.0 | 8.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.0 | 3.0 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
1.0 | 75.0 | GO:0032432 | actin filament bundle(GO:0032432) |
0.9 | 1.9 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.9 | 13.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.9 | 4.6 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.9 | 3.7 | GO:0033503 | HULC complex(GO:0033503) |
0.9 | 13.7 | GO:0016580 | Sin3 complex(GO:0016580) |
0.9 | 2.7 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.9 | 125.0 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.9 | 2.7 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.9 | 4.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.9 | 10.3 | GO:1990752 | microtubule end(GO:1990752) |
0.9 | 2.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.9 | 5.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.9 | 6.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.8 | 16.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.8 | 4.9 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.8 | 9.4 | GO:0030056 | hemidesmosome(GO:0030056) |
0.8 | 24.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.8 | 4.7 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.8 | 19.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.8 | 19.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.8 | 13.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.8 | 8.4 | GO:0016600 | flotillin complex(GO:0016600) |
0.7 | 3.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.7 | 4.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.7 | 11.0 | GO:0097449 | astrocyte projection(GO:0097449) |
0.7 | 5.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.7 | 10.9 | GO:0001741 | XY body(GO:0001741) |
0.7 | 6.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.7 | 2.2 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.7 | 12.8 | GO:0031672 | A band(GO:0031672) |
0.7 | 18.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.7 | 26.9 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.7 | 5.5 | GO:0016589 | NURF complex(GO:0016589) |
0.7 | 4.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.7 | 2.7 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.7 | 3.4 | GO:0097361 | CIA complex(GO:0097361) |
0.7 | 18.9 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.7 | 30.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.7 | 21.4 | GO:0005921 | gap junction(GO:0005921) |
0.6 | 6.5 | GO:0045180 | basal cortex(GO:0045180) |
0.6 | 4.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.6 | 10.3 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.6 | 11.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.6 | 36.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.6 | 27.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.6 | 15.9 | GO:0044295 | axonal growth cone(GO:0044295) |
0.6 | 3.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.5 | 19.2 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.5 | 4.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.5 | 3.3 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.5 | 3.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.5 | 5.4 | GO:0071564 | npBAF complex(GO:0071564) |
0.5 | 4.8 | GO:0033270 | paranode region of axon(GO:0033270) |
0.5 | 11.6 | GO:0034706 | sodium channel complex(GO:0034706) |
0.5 | 4.2 | GO:0070187 | telosome(GO:0070187) |
0.5 | 25.7 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.5 | 9.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.5 | 46.1 | GO:0016605 | PML body(GO:0016605) |
0.5 | 12.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.5 | 5.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.5 | 2.8 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.5 | 5.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.5 | 9.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.5 | 3.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 4.4 | GO:0002177 | manchette(GO:0002177) |
0.4 | 2.6 | GO:0030914 | STAGA complex(GO:0030914) |
0.4 | 32.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.4 | 2.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 30.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.4 | 1.7 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.4 | 4.9 | GO:0000812 | Swr1 complex(GO:0000812) |
0.4 | 5.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.4 | 11.2 | GO:0030286 | dynein complex(GO:0030286) |
0.4 | 2.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.4 | 4.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.4 | 42.1 | GO:0030017 | sarcomere(GO:0030017) |
0.4 | 4.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.4 | 0.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.4 | 22.0 | GO:0034707 | chloride channel complex(GO:0034707) |
0.4 | 0.8 | GO:0000974 | Prp19 complex(GO:0000974) |
0.4 | 6.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.4 | 7.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.4 | 10.5 | GO:0002102 | podosome(GO:0002102) |
0.3 | 3.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.3 | 7.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 1.7 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.3 | 5.5 | GO:0005686 | U2 snRNP(GO:0005686) |
0.3 | 1.3 | GO:0035363 | histone locus body(GO:0035363) |
0.3 | 80.1 | GO:0005874 | microtubule(GO:0005874) |
0.3 | 0.9 | GO:0000811 | GINS complex(GO:0000811) |
0.3 | 5.0 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.3 | 1.8 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.3 | 0.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 3.9 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 2.4 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 2.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.3 | 1.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 2.6 | GO:0032009 | early phagosome(GO:0032009) |
0.3 | 3.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.3 | 1.4 | GO:0089701 | U2AF(GO:0089701) |
0.3 | 24.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 0.8 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.3 | 17.4 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.3 | 63.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.3 | 6.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 4.8 | GO:0019013 | viral nucleocapsid(GO:0019013) |
0.3 | 66.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.2 | 13.7 | GO:0016234 | inclusion body(GO:0016234) |
0.2 | 2.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 6.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 11.6 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 2.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 1.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 1.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 2.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 2.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 1.6 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 0.6 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 1.2 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.2 | 42.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 5.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 0.7 | GO:1990745 | GARP complex(GO:0000938) EARP complex(GO:1990745) |
0.2 | 4.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 14.5 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 0.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 6.1 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 11.3 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 8.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 4.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 1.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 1.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 3.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.4 | GO:0097227 | septin complex(GO:0031105) sperm annulus(GO:0097227) |
0.1 | 14.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 5.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 1.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.4 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 65.2 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 1.0 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 1.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 1.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 1.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.3 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 1.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 3.2 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 0.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 1.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 1.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 1.3 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 1.7 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.6 | 37.7 | GO:0031720 | haptoglobin binding(GO:0031720) |
10.4 | 31.1 | GO:0035939 | microsatellite binding(GO:0035939) |
7.0 | 126.9 | GO:0044548 | S100 protein binding(GO:0044548) |
6.7 | 80.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
6.4 | 25.5 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
6.2 | 18.5 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
6.0 | 24.1 | GO:0035877 | death effector domain binding(GO:0035877) |
5.7 | 40.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
5.7 | 39.7 | GO:0031014 | troponin T binding(GO:0031014) |
5.6 | 16.8 | GO:0016403 | dimethylargininase activity(GO:0016403) |
5.6 | 67.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
5.6 | 22.4 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
5.4 | 16.2 | GO:0048030 | disaccharide binding(GO:0048030) |
5.1 | 20.4 | GO:0042610 | CD8 receptor binding(GO:0042610) |
5.0 | 15.1 | GO:0033222 | xylose binding(GO:0033222) |
4.9 | 14.6 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
4.4 | 17.6 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
4.4 | 26.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
4.4 | 43.7 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
4.2 | 12.7 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
4.1 | 12.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
4.0 | 19.8 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
3.8 | 19.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
3.8 | 19.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
3.6 | 14.6 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
3.5 | 28.0 | GO:0071253 | connexin binding(GO:0071253) |
3.4 | 17.0 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
3.3 | 19.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
3.2 | 19.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
3.2 | 32.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
3.2 | 22.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
3.2 | 35.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
3.2 | 9.5 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) glycoprotein transporter activity(GO:0034437) |
3.0 | 76.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
3.0 | 9.1 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
3.0 | 21.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
3.0 | 33.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
2.9 | 17.5 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
2.9 | 11.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
2.9 | 11.5 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
2.9 | 14.3 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
2.7 | 8.2 | GO:0046592 | polyamine oxidase activity(GO:0046592) |
2.7 | 8.2 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
2.7 | 35.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
2.7 | 5.3 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
2.7 | 21.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
2.6 | 7.9 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
2.6 | 13.1 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
2.6 | 7.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
2.6 | 7.7 | GO:0046980 | peptide antigen-transporting ATPase activity(GO:0015433) tapasin binding(GO:0046980) |
2.6 | 33.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
2.5 | 17.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
2.4 | 19.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
2.4 | 9.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
2.4 | 7.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
2.3 | 45.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
2.2 | 10.9 | GO:0042731 | PH domain binding(GO:0042731) |
2.1 | 12.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
2.1 | 14.8 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
2.0 | 14.3 | GO:0030274 | LIM domain binding(GO:0030274) |
2.0 | 20.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
2.0 | 31.6 | GO:0051400 | BH domain binding(GO:0051400) |
2.0 | 17.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
1.9 | 3.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
1.9 | 45.8 | GO:0005112 | Notch binding(GO:0005112) |
1.9 | 15.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
1.9 | 26.4 | GO:0031432 | titin binding(GO:0031432) |
1.9 | 9.4 | GO:0048495 | Roundabout binding(GO:0048495) |
1.8 | 25.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.8 | 5.5 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
1.8 | 36.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.8 | 7.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.7 | 10.3 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
1.7 | 6.7 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) G-protein coupled neurotensin receptor activity(GO:0016492) |
1.7 | 16.5 | GO:0003680 | AT DNA binding(GO:0003680) |
1.6 | 25.7 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
1.6 | 7.9 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
1.6 | 6.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.6 | 3.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
1.6 | 6.2 | GO:0015265 | urea channel activity(GO:0015265) |
1.6 | 6.2 | GO:0045159 | myosin II binding(GO:0045159) |
1.5 | 18.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.5 | 9.2 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
1.5 | 4.5 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
1.5 | 9.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.5 | 2.9 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
1.5 | 5.9 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.4 | 2.8 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
1.4 | 35.5 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
1.4 | 6.8 | GO:0031849 | olfactory receptor binding(GO:0031849) |
1.3 | 9.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.3 | 8.0 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.3 | 4.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
1.3 | 3.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.3 | 17.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.3 | 13.0 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.3 | 15.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
1.3 | 3.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.3 | 43.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.3 | 11.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
1.3 | 3.8 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
1.2 | 13.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
1.2 | 38.5 | GO:0043236 | laminin binding(GO:0043236) |
1.2 | 7.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
1.2 | 31.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.2 | 4.8 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.2 | 4.7 | GO:0051425 | PTB domain binding(GO:0051425) |
1.2 | 21.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.2 | 4.7 | GO:0032896 | stearoyl-CoA 9-desaturase activity(GO:0004768) palmitoyl-CoA 9-desaturase activity(GO:0032896) |
1.1 | 8.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.1 | 8.0 | GO:0003896 | DNA primase activity(GO:0003896) |
1.1 | 9.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.1 | 3.4 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
1.1 | 15.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
1.1 | 6.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.1 | 11.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.1 | 3.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
1.1 | 20.7 | GO:0001618 | virus receptor activity(GO:0001618) |
1.1 | 4.3 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
1.1 | 6.5 | GO:0050692 | DBD domain binding(GO:0050692) |
1.1 | 11.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.0 | 9.4 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
1.0 | 3.1 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
1.0 | 3.1 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
1.0 | 8.3 | GO:1990459 | transferrin receptor binding(GO:1990459) |
1.0 | 8.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.0 | 7.3 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
1.0 | 3.1 | GO:0031770 | growth hormone-releasing hormone receptor binding(GO:0031770) |
1.0 | 19.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
1.0 | 4.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.0 | 5.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
1.0 | 4.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.0 | 12.1 | GO:0035198 | miRNA binding(GO:0035198) |
1.0 | 6.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.0 | 7.0 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.0 | 5.9 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.0 | 5.8 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
1.0 | 3.8 | GO:0031013 | troponin I binding(GO:0031013) |
1.0 | 5.7 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
1.0 | 2.9 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.9 | 3.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.9 | 14.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.9 | 16.0 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.9 | 10.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.9 | 10.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.9 | 16.3 | GO:0005522 | profilin binding(GO:0005522) |
0.9 | 7.2 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.9 | 10.7 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.9 | 77.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.9 | 21.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.9 | 3.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.9 | 2.6 | GO:0005135 | interleukin-3 receptor binding(GO:0005135) |
0.9 | 3.5 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.9 | 17.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.9 | 25.6 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.8 | 19.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.8 | 2.4 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.8 | 8.6 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.8 | 3.1 | GO:1990955 | G-rich single-stranded DNA binding(GO:1990955) |
0.8 | 10.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.8 | 23.4 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.8 | 9.0 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.7 | 11.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.7 | 7.4 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.7 | 3.7 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.7 | 1.5 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.7 | 3.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.7 | 7.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.7 | 16.9 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.7 | 5.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.7 | 2.8 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.7 | 16.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.7 | 33.7 | GO:0070888 | E-box binding(GO:0070888) |
0.7 | 2.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.7 | 21.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.7 | 0.7 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.7 | 5.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.7 | 2.7 | GO:0036033 | mediator complex binding(GO:0036033) |
0.7 | 30.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.7 | 7.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.7 | 10.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.7 | 30.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.7 | 3.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.7 | 2.6 | GO:0032190 | acrosin binding(GO:0032190) |
0.6 | 1.9 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.6 | 1.9 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.6 | 1.9 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.6 | 5.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.6 | 6.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.6 | 3.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.6 | 1.8 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.6 | 12.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.6 | 3.5 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.6 | 1.7 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.6 | 4.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.6 | 1.7 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.6 | 21.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.6 | 6.6 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.5 | 4.3 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.5 | 4.9 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.5 | 4.8 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.5 | 37.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.5 | 4.3 | GO:0043515 | kinetochore binding(GO:0043515) |
0.5 | 8.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.5 | 7.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.5 | 1.6 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.5 | 2.1 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
0.5 | 2.1 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.5 | 4.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.5 | 41.3 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.5 | 121.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.5 | 5.4 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.5 | 4.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 53.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.5 | 1.9 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
0.5 | 12.9 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.5 | 5.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 3.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.5 | 1.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.5 | 4.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.4 | 6.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.4 | 7.9 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 1.3 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.4 | 2.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.4 | 3.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 11.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.4 | 2.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.4 | 14.4 | GO:0003774 | motor activity(GO:0003774) |
0.4 | 6.2 | GO:0015926 | glucosidase activity(GO:0015926) |
0.4 | 6.5 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
0.4 | 4.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.4 | 21.2 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.4 | 3.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.4 | 103.9 | GO:0015631 | tubulin binding(GO:0015631) |
0.4 | 2.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.4 | 7.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.4 | 7.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.4 | 2.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.4 | 1.2 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.4 | 1.9 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.4 | 6.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.4 | 4.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.4 | 19.0 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.4 | 1.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 1.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.4 | 26.4 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.4 | 1.8 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.3 | 16.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 0.7 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.3 | 4.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 11.1 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.3 | 2.7 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.3 | 7.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 1.0 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.3 | 3.3 | GO:0051378 | serotonin binding(GO:0051378) |
0.3 | 3.0 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.3 | 1.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.3 | 9.8 | GO:0005518 | collagen binding(GO:0005518) |
0.3 | 2.6 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.3 | 40.2 | GO:0008201 | heparin binding(GO:0008201) |
0.3 | 23.8 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.3 | 15.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.3 | 12.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.3 | 15.1 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.3 | 2.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.3 | 2.7 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) ferrous iron transmembrane transporter activity(GO:0015093) |
0.3 | 2.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 3.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.3 | 8.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 8.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.3 | 6.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 2.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 10.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.3 | 14.6 | GO:0019003 | GDP binding(GO:0019003) |
0.3 | 0.8 | GO:0042979 | ornithine decarboxylase activator activity(GO:0042978) ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 9.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 3.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 3.2 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 5.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 4.4 | GO:0019239 | deaminase activity(GO:0019239) |
0.2 | 2.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 4.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 1.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 4.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 4.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 13.7 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.2 | 0.7 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.2 | 1.4 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.2 | 4.3 | GO:0005234 | ionotropic glutamate receptor activity(GO:0004970) extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.2 | 2.5 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 2.4 | GO:0097200 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.2 | 7.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 11.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 1.9 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.2 | 3.1 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 5.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 2.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 2.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 26.6 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.2 | 4.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 3.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 3.6 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.2 | 1.6 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.2 | 0.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 5.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 7.4 | GO:0035064 | methylated histone binding(GO:0035064) |
0.2 | 7.8 | GO:0004386 | helicase activity(GO:0004386) |
0.2 | 2.0 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 3.0 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.2 | 14.8 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.2 | 2.2 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.2 | 2.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 10.6 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 1.9 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 6.3 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 10.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 11.5 | GO:0005516 | calmodulin binding(GO:0005516) |
0.1 | 10.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 5.7 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.9 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 9.6 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 8.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 3.1 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 0.9 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 11.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 3.9 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 7.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 9.9 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.4 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 1.0 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 15.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 1.4 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 3.5 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 2.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 3.6 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.1 | 0.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 1.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 12.9 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.6 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 12.9 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.6 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 13.5 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 1.7 | GO:0016247 | channel regulator activity(GO:0016247) |
0.0 | 0.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.3 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.2 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.4 | GO:0015216 | purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.4 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 2.9 | GO:0030246 | carbohydrate binding(GO:0030246) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 73.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
3.8 | 64.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
2.4 | 9.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
2.4 | 23.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
2.2 | 31.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
2.2 | 57.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
2.1 | 21.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
1.8 | 31.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.8 | 28.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.7 | 8.6 | ST STAT3 PATHWAY | STAT3 Pathway |
1.6 | 16.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
1.6 | 32.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
1.5 | 36.9 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
1.4 | 109.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.4 | 40.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.4 | 16.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.4 | 38.0 | PID RAS PATHWAY | Regulation of Ras family activation |
1.3 | 38.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
1.3 | 59.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.3 | 5.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
1.2 | 18.7 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
1.2 | 3.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.2 | 56.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
1.1 | 169.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
1.1 | 2.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.1 | 16.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.0 | 15.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
1.0 | 47.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
1.0 | 17.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.0 | 18.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.0 | 7.6 | PID EPO PATHWAY | EPO signaling pathway |
0.9 | 18.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.9 | 5.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.9 | 38.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.9 | 12.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.9 | 16.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.9 | 37.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.9 | 8.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.9 | 17.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.9 | 16.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.8 | 14.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.8 | 2.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.8 | 35.6 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.8 | 15.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.8 | 7.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.8 | 26.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.8 | 20.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.8 | 37.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.7 | 6.7 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.7 | 8.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.7 | 12.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.6 | 15.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.6 | 12.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.6 | 3.7 | PID MYC PATHWAY | C-MYC pathway |
0.6 | 22.6 | PID P53 REGULATION PATHWAY | p53 pathway |
0.6 | 11.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.6 | 21.8 | PID ATM PATHWAY | ATM pathway |
0.6 | 6.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.6 | 6.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.5 | 3.7 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.5 | 5.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.5 | 1.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.5 | 19.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.5 | 15.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.5 | 21.0 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.5 | 0.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.5 | 127.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.5 | 20.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.4 | 5.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.4 | 19.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.4 | 4.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 5.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.4 | 8.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.4 | 91.2 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.4 | 3.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 4.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.3 | 2.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 11.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 8.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 8.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.3 | 2.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.3 | 3.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 10.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 3.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 2.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 3.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 3.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 6.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 36.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 8.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 4.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 4.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 3.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 0.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 1.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 3.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 1.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 0.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 3.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 41.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
2.4 | 7.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
2.4 | 92.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
2.3 | 36.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
2.2 | 17.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
2.1 | 34.9 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
1.9 | 52.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.5 | 52.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
1.4 | 42.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.4 | 2.8 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
1.4 | 12.7 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
1.4 | 25.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.4 | 41.8 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
1.4 | 16.5 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.3 | 25.0 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
1.3 | 6.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
1.2 | 6.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.2 | 7.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.2 | 23.6 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
1.2 | 29.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.1 | 14.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
1.1 | 6.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.1 | 15.7 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
1.1 | 17.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.1 | 37.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.1 | 17.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
1.1 | 18.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.1 | 10.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
1.1 | 55.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.1 | 102.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
1.0 | 7.2 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
1.0 | 28.8 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
1.0 | 10.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.0 | 8.0 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.9 | 43.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.9 | 6.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.9 | 43.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.8 | 21.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.8 | 10.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.8 | 24.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.8 | 21.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.8 | 7.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.8 | 12.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.8 | 8.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.7 | 17.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.7 | 13.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.7 | 9.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.7 | 12.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.7 | 12.6 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.7 | 13.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.7 | 30.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.6 | 8.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.6 | 2.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.6 | 26.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.6 | 10.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.6 | 7.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.6 | 22.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.6 | 13.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.5 | 5.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.5 | 38.9 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.5 | 9.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.5 | 4.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.5 | 29.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.5 | 12.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.5 | 4.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.5 | 8.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.5 | 5.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.5 | 11.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.5 | 12.9 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.5 | 51.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.5 | 1.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.4 | 21.0 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.4 | 2.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.4 | 4.9 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.4 | 5.2 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.4 | 18.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.4 | 3.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.4 | 15.3 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.4 | 6.5 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.4 | 15.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.4 | 3.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.4 | 14.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.4 | 1.9 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.4 | 13.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.4 | 2.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 3.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.4 | 11.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.4 | 4.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.4 | 8.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.4 | 10.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 2.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.3 | 1.4 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.3 | 6.5 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.3 | 19.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 15.9 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.3 | 0.9 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
0.3 | 4.3 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.3 | 1.8 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.3 | 3.6 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.3 | 9.5 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.3 | 3.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 21.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 25.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 1.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.3 | 3.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 2.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 9.3 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.2 | 4.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 1.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 5.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 1.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 2.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 5.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 3.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 3.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 3.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 0.7 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 2.8 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 2.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 2.0 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 4.0 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 2.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 2.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 4.9 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 4.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.6 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.1 | 1.5 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.1 | 4.5 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.1 | 0.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 1.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 2.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 6.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 4.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.7 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 0.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 0.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 1.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 3.6 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 3.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 1.1 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |